Richard D. Truesdell, Jr.
Lawyers
Filters
Hamilton Lane $155.2 Million Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $155.2 million SEC-registered follow-on offering of 4,531,001 shares of Class A common stock of Hamilton Lane…
Davis Polk Advises Pattern Energy’s Conflicts Committee on the Entry into Japan Market with Acquisition of Wind and Solar Projects
Davis Polk is advising the Conflicts Committee of the board of directors of Pattern Energy Group Inc. in connection with Pattern Energy’s approximately $325.5 million acquisition of 206…
OneMain Holdings, Inc. $130 Million Common Stock Offering
Davis Polk advised the underwriter in connection with the SEC-registered offering of 4,179,678 shares of common stock of OneMain Holdings, Inc. sold by Springleaf Financial Holdings, LLC on…
Davis Polk Advises Fogo de Chão on Its Acquisition by Rhône
Davis Polk is advising Fogo de Chão, Inc. on its $560 million acquisition by Rhône Capital. The transaction is expected to be completed during the second quarter of 2018, subject to…
Celgene $4.5 Billion Notes Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by Celgene Corporation of $500 million aggregate…
Davis Polk Advises EnVen Energy Corporation on Its $325 Million High-Yield Notes Offering
Davis Polk advised EnVen Energy Corporation in connection with a Rule 144A/Regulation S offering of $325 million aggregate principal amount of its 11.000% senior secured second-lien notes…
Davis Polk Advises Charles River on Its Acquisition of MPI Research
Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $800 million acquisition of MPI Research Inc. The transaction, which is expected to close early in…
ConforMIS, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering of 13,333,333 shares of common stock of ConforMis,…
Stemline Therapeutics, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 4,255,000 shares of common stock of…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 8,152,986 shares of common stock of…